By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


UCB, Inc. 

1950 Lake Park Drive

Smyrna  Georgia  30080  U.S.A.
Phone: 770-437-5705 Fax: 770-437-5640



The Medicines Company  Contract manufacturing of Bivalirudin peptide active ingredient

Praecis Pharmaceuticals Incorporated  Contract manufacturing of Abarelix peptide active ingredient

Bausch & Lomb  Contract manufacturing of active pharmaceutical ingredient

Company News
UCB, Inc. (UCBJF.PK) Opens Solution Accelerator At Georgia Tech Technology Square 9/20/2016 9:05:33 AM
UCB, Inc. (UCBJF.PK) Receives EMA Regulatory Approval For Pre-filled Pen With Core Bespak Technology 9/19/2016 11:43:04 AM
Argentum Succeeds In Starting Patent Cancellation Trial Against UCB, Inc. (UCBJF.PK)'s VIMPAT 5/24/2016 6:27:49 AM
Evotec AG (EVTG.F) And UCB, Inc. (UCBJF.PK) Sign Multi-Year Sample Management Agreement 1/7/2016 1:26:31 PM
UCB, Inc. (UCBJF.PK) Works With Congenica To Support Rare Disease Genomic Research 12/17/2015 11:00:11 AM
Sinequa Selected By UCB, Inc. (UCBJF.PK) To Reduce Time And Cost Of Searching Clinical Trial Data 12/16/2015 10:33:51 AM
Important UCB, Inc. (UCBJF.PK) Presence At The 2015 American Academy of Neurology Meeting 4/21/2015 1:20:16 PM
UCB, Inc. (UCBJF.PK) Announces US And EU Regulatory Filings For The Investigational Antiepileptic Drug brivaracetam 1/21/2015 10:05:14 AM
UCB, Inc. (UCBJF.PK) Shows Strong Scientific Presence At Leading Rheumatology Meeting 11/14/2014 8:00:17 AM
UCB, Inc. (UCBJF.PK)-sponsored Data On Cimzia® (certolizumab pegol) To Be Highlighted At American College of Gastroenterology 2014 Annual Scientific Meeting 10/22/2014 11:15:01 AM